Financial results - VISAN MEDICAL SRL

Financial Summary - Visan Medical Srl
Unique identification code: 22908635
Registration number: J40/23248/2007
Nace: 8622
Sales - Ron
140.847
Net Profit - Ron
110.742
Employee
1
The most important financial indicators for the company Visan Medical Srl - Unique Identification Number 22908635: sales in 2023 was 140.847 euro, registering a net profit of 110.742 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Visan Medical Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 38.603 62.111 55.409 64.994 66.853 74.301 80.647 90.725 103.680 140.847
Total Income - EUR 38.603 62.111 55.409 64.994 66.853 85.722 85.255 91.130 104.073 140.848
Total Expenses - EUR 11.191 40.978 38.288 38.583 25.337 43.178 30.443 26.333 32.208 28.726
Gross Profit/Loss - EUR 27.412 21.133 17.121 26.411 41.516 42.544 54.812 64.797 71.865 112.123
Net Profit/Loss - EUR 26.254 19.270 15.458 24.101 39.511 40.377 53.003 62.118 69.524 110.742
Employees 0 0 0 0 0 0 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 36.3%, from 103.680 euro in the year 2022, to 140.847 euro in 2023. The Net Profit increased by 41.429 euro, from 69.524 euro in 2022, to 110.742 in the last year.

Check the financial reports for the company - Visan Medical Srl

Rating financiar

Financial Rating -
Visan Medical Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Visan Medical Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Visan Medical Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Visan Medical Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Visan Medical Srl - CUI 22908635

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 892 675 28.494 22.702 17.074 50.834 41.353 30.996 21.623 12.192
Current Assets 23.898 43.453 58.675 17.302 42.793 19.835 45.757 48.518 127.288 100.616
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 2.520 225 111 0 296 12.455 9.243 9.038 9.016 74.698
Cash 21.378 43.228 58.563 17.302 42.497 7.380 36.515 39.481 118.272 25.918
Shareholders Funds 23.990 43.460 58.475 15.913 39.562 46.225 86.032 79.948 149.720 110.791
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 800 668 28.694 24.091 20.305 24.444 1.078 520 102 3.087
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 100.616 euro in 2023 which includes Inventories of 0 euro, Receivables of 74.698 euro and cash availability of 25.918 euro.
The company's Equity was valued at 110.791 euro, while total Liabilities amounted to 3.087 euro. Equity decreased by -38.475 euro, from 149.720 euro in 2022, to 110.791 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Visan Medical Srl

Comments - Visan Medical Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.